UNCY logo

Unicycive Therapeutics (UNCY) Cash From Financing

Annual CFF

$27.54 M
+$28.01 M+5947.35%

December 31, 2023


Summary


Performance

UNCY Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherUNCYcash flowmetrics:

Quarterly CFF

-$157.00 K
+$654.00 K+80.64%

September 30, 2024


Summary


Performance

UNCY Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherUNCYcash flowmetrics:

TTM CFF

$44.52 M
-$106.00 K-0.24%

September 30, 2024


Summary


Performance

UNCY TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherUNCYcash flowmetrics:

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

UNCY Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+5947.4%+23.4%+61.6%
3 y3 years+1807.3%+23.4%+61.6%
5 y5 years+2262.0%+23.4%+61.6%

UNCY Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+5947.4%-100.3%+80.6%-2.0%+9551.8%
5 y5-yearat high+5947.4%-100.3%+80.6%-2.0%+9551.8%
alltimeall timeat high+5947.4%-100.3%+80.6%-2.0%+9551.8%

Unicycive Therapeutics Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2024
-
-$157.00 K(-80.6%)
$44.52 M(-0.2%)
Jun 2024
-
-$811.00 K(-101.8%)
$44.62 M(-1.8%)
Mar 2024
-
$45.69 M(<-9900.0%)
$45.44 M(+65.0%)
Dec 2023
$27.54 M(-5947.3%)
-$205.00 K(+302.0%)
$27.54 M(+1.0%)
Sep 2023
-
-$51.00 K(<-9900.0%)
$27.27 M(-0.2%)
Jun 2023
-
$0.00(-100.0%)
$27.33 M(0.0%)
Mar 2023
-
$27.80 M(-6001.7%)
$27.33 M(-5901.7%)
Dec 2022
-$471.00 K
-$471.00 K(<-9900.0%)
-$471.00 K(<-9900.0%)
Sep 2022
-
$0.00(0.0%)
$0.00(-100.0%)
Jun 2022
-
$0.00(0.0%)
$21.48 M(-0.3%)
DateAnnualQuarterlyTTM
Mar 2022
-
$0.00(0.0%)
$21.55 M(-3.7%)
Dec 2021
$22.38 M(+1449.5%)
$0.00(-100.0%)
$22.38 M(-2.1%)
Sep 2021
-
$21.48 M(>+9900.0%)
$22.85 M(+970.8%)
Jun 2021
-
$71.00 K(-91.3%)
$2.13 M(-3.2%)
Mar 2021
-
$820.00 K(+72.6%)
$2.20 M(+52.6%)
Dec 2020
$1.44 M(+23.8%)
-
-
Dec 2020
-
$475.00 K(-38.2%)
$1.44 M(+49.0%)
Sep 2020
-
$768.00 K(+444.7%)
$969.00 K(+382.1%)
Jun 2020
-
$141.00 K(+135.0%)
$201.00 K(+235.0%)
Mar 2020
-
$60.00 K
$60.00 K
Dec 2019
$1.17 M
-
-

FAQ

  • What is Unicycive Therapeutics annual cash flow from financing activities?
  • What is the all time high annual CFF for Unicycive Therapeutics?
  • What is Unicycive Therapeutics annual CFF year-on-year change?
  • What is Unicycive Therapeutics quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Unicycive Therapeutics?
  • What is Unicycive Therapeutics quarterly CFF year-on-year change?
  • What is Unicycive Therapeutics TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Unicycive Therapeutics?
  • What is Unicycive Therapeutics TTM CFF year-on-year change?

What is Unicycive Therapeutics annual cash flow from financing activities?

The current annual CFF of UNCY is $27.54 M

What is the all time high annual CFF for Unicycive Therapeutics?

Unicycive Therapeutics all-time high annual cash flow from financing activities is $27.54 M

What is Unicycive Therapeutics annual CFF year-on-year change?

Over the past year, UNCY annual cash flow from financing activities has changed by +$28.01 M (+5947.35%)

What is Unicycive Therapeutics quarterly cash flow from financing activities?

The current quarterly CFF of UNCY is -$157.00 K

What is the all time high quarterly CFF for Unicycive Therapeutics?

Unicycive Therapeutics all-time high quarterly cash flow from financing activities is $45.69 M

What is Unicycive Therapeutics quarterly CFF year-on-year change?

Over the past year, UNCY quarterly cash flow from financing activities has changed by +$48.00 K (+23.41%)

What is Unicycive Therapeutics TTM cash flow from financing activities?

The current TTM CFF of UNCY is $44.52 M

What is the all time high TTM CFF for Unicycive Therapeutics?

Unicycive Therapeutics all-time high TTM cash flow from financing activities is $45.44 M

What is Unicycive Therapeutics TTM CFF year-on-year change?

Over the past year, UNCY TTM cash flow from financing activities has changed by +$16.98 M (+61.64%)